← SynDRA
AT-9283
SynDRA canonical compound SYN0016409 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | AURKB |
|---|
| Mechanism of action | Protein kinase inhibitor |
|---|
All known targets
- AURKA
- AURKB
- JAK2
- JAK3
- ABL1
- FLT3
- RPS6KA6
- STK17A
- BCR
Mechanisms of action (all sources)
- JAK inhibitor
- FLT3 INHIBITOR
- Mitotic inhibitor
- Abl kinase inhibitor
- aurora kinase inhibitor
- Protein kinase inhibitor
- ABL1 INHIBITOR
- Tyrosine-protein kinase ABL inhibitor
- AURKA INHIBITOR
- Serine/threonine-protein kinase Aurora-A inhibitor
- AURKB INHIBITOR
- Serine/threonine-protein kinase Aurora-B inhibitor
Cross-references
Synonyms
- AT9283
- XAV9KYN9WL
- AT 9283 [WHO-DD]
- RefChem:560290
- Multikinase Inhibitor AT9283
- Aurora kinase inhibitor AT9283
- AT-9283 free base
- MFCD12031513
- AT 9283, (2S)-2-hydroxy-propanoic acid salt
- UNII-XAV9KYN9WL
- C19H23N7O2
- MLS006011044
- SCHEMBL545809
- SCHEMBL545942
- GTPL7949
- orb1304573
- SCHEMBL15005492
- SCHEMBL15005494
- SCHEMBL24336623
- SCHEMBL29353018
- BDBM27087
- EX-A201
- CHEBI:125514
- LOLPPWBBNUVNQZ-UHFFFAOYSA-N
- GLXC-06792
- HMS3244O09
- HMS3244O10
- HMS3244P09
- HMS3654G08
- HMS3673I15
- BDBM50243388
- EBC-79023
- NSC760144
- NSC799339
- s1134
- AKOS016006006
- AKOS026750645
- AT9 283
Look up AT-9283 in the interactive SynDRA portal →